亚洲欧美不卡高清在线观看,伊人久久大香线蕉午夜av,亚洲综合色区在线观看,中文在线中文a,真正免费的毛片

  • Farxiga Meets Primary Endpoint in Heart Failure Trial americanpharmaceuticalreview
    August 21, 2019
    AstraZeneca has announced positive results from the landmark Phase III DAPA-HF trial which showed that?Farxiga?(dapagliflozin) met the primary composite endpoint with a statistically-significant and clinically-meaningful reduction of ...
  • Entresto tops mainstay ACE inhibitor in heart failure trial pharmaphorum
    December 04, 2018
    Two years ago, Novartis launched a big trials programme for its heart failure drug Entresto in the hope of revving up disappointing initial sales, and one of those trials has just delivered positive results.
PharmaSources Customer Service